Cas:175136-66-0 bis[3,5-bis(trifluoromethyl)phenyl]methanone manufacturer & supplier

Chemical Name:bis[3,5-bis(trifluoromethyl)phenyl]methanone

CAS.NO:175136-66-0

Synonyms:3,3′,5,5′-Tetrakis(trifluoromethyl)benzophenone;MFCD00042474;HMS549N11

Molecular Formula:C₁₇H₆F₁₂O

Molecular Weight:454.21000

HS Code:

Physical and Chemical Properties:

Melting point:139-140°C

Boiling point:325.2ºC at 760 mmHg

Density:1.506g/cm3

Index of Refraction:1.417

PSA:17.07000

Exact Mass:454.02300

LogP:6.99280

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,3′,5,5′-Tetrakis(trifluoromethyl)benzophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HMS549N11 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00042474 Use and application,HMS549N11 technical grade,usp/ep/jp grade.

Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. bis[3,5-bis(trifluoromethyl)phenyl]methanone manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. bis[3,5-bis(trifluoromethyl)phenyl]methanone supplier This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them. bis[3,5-bis(trifluoromethyl)phenyl]methanone vendor Government officials say that the number of visitors from the mainland and other countries has decreased significantly after they closed several border points and rail stations and cut flight arrivals by half. bis[3,5-bis(trifluoromethyl)phenyl]methanone factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.